Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...
The New Year is a time of reflection and change for many Americans, who start each January with a clean slate and goals for ...
More than 90 per cent of weight loss jab users are forced to pay for treatment privately due to their slow roll-out on the ...